Structural Heart

View the latest content related to this topic

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Todd Neale

April 11, 2025

Slides

See all

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

Presentation CTO 2025

Complications Associated With Edwards SAPIEN vs Medtronic CoreValve Revalving Systems: An Analysis of the MAUDE Database

Presenter: Christian Fang

February 28, 2025

Presentation Miami Valves 2025

Where Are We With TAVR for Bicuspid?

Presenter: Nicolas M Van Mieghem

January 30, 2025

Presentation Miami Valves 2025

Valve Embolization in the Ventricle Managed Percutaneously

Presenter: Gennaro Giustino

January 30, 2025

News

See all

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

By Todd Neale

April 11, 2025

News Conference News EHRA 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

By Todd Neale

April 09, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

By Todd Neale

April 08, 2025

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

By L.A. McKeown

April 07, 2025

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

By L.A. McKeown

April 04, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Structural Heart

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Slides

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Dapagliflozin after Transcatheter Aortic Valve Implantation

Complications Associated With Edwards SAPIEN vs Medtronic CoreValve Revalving Systems: An Analysis of the MAUDE Database

Where Are We With TAVR for Bicuspid?

Valve Embolization in the Ventricle Managed Percutaneously

News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

CMS Releases Proposed Decision Memo for Tricuspid TEER

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Structural Heart

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content